Telomir Pharmaceuticals Inc. (NASDAQ: TELO) announced that the Food and Drug Administration cleared its Investigational New Drug application for Telomir-Zn ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE